These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 5888826)

  • 21. Treatment of radiation-induced nodular goiters.
    De Papp ZG; Pincus RA; Hempelmann LH
    J Nucl Med; 1970 Aug; 11(8):496-502. PubMed ID: 5451718
    [No Abstract]   [Full Text] [Related]  

  • 22. [Radiation treatment of cancer of the thyroid].
    Yamashita H; Matsubayashi T; Kubo A; Yoshioka T
    Gan No Rinsho; 1970 Aug; 16(8):771-85. PubMed ID: 4989462
    [No Abstract]   [Full Text] [Related]  

  • 23. [Considerations on the treatment of thyroid cancer].
    Dargent M
    Sem Hop; 1967 Jun; 43(30):1949-58. PubMed ID: 4308881
    [No Abstract]   [Full Text] [Related]  

  • 24. [Thyroid nodule: diagnostic and therapeutic problems].
    Jaffiol C
    Sem Hop; 1969 Jun; 45(29):2031-2. PubMed ID: 4308658
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the diagnosis and treatment of diseases of the thyroid gland with radioactive iodine].
    Egorov PI; Tsfasman AZ
    Ter Arkh; 1967 Mar; 39(3):5-9. PubMed ID: 4894050
    [No Abstract]   [Full Text] [Related]  

  • 26. Diuretic augmentation of 131-I uptake in inoperable thyroid cancer.
    Hamburger JI
    N Engl J Med; 1969 May; 280(20):1091-4. PubMed ID: 5778423
    [No Abstract]   [Full Text] [Related]  

  • 27. [Therapy of malignant tumors of the thyroid gland].
    Gubler R
    Schweiz Med Wochenschr; 1966 Feb; 96(8):253-8. PubMed ID: 4963962
    [No Abstract]   [Full Text] [Related]  

  • 28. [Hormonal therapy in differentiated carcinoma of the thyroid gland].
    Francia G; Davì MV; Petroziello A; Sussi PL
    Chir Ital; 1994; 46(4):56-8. PubMed ID: 7882445
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adequacy of TSH suppression by L-thyroxine administration in thyroid cancer patients after total thyroidectomy.
    Pinchera A; Martino E; Bartalena L; Pacchiarotti A; Aghini-Lombardi F; Grasso L
    J Endocrinol Invest; 1986; 9 Suppl 4():77-88. PubMed ID: 3559056
    [No Abstract]   [Full Text] [Related]  

  • 30. Experience with thyroid malignancy in a private referral laboratory.
    Hamburger JI
    Mich Med; 1969 Jun; 68(11):575-80. PubMed ID: 5789647
    [No Abstract]   [Full Text] [Related]  

  • 31. Thyroid cancer: medical management.
    Strong JA
    Recent Results Cancer Res; 1980; 73():124-8. PubMed ID: 7232813
    [No Abstract]   [Full Text] [Related]  

  • 32. [Current treatment of cancer of the thyroid (study of a series of 58 cases)].
    Gary-Bobo J; Pourquier H; Pujol H; Solassol C; Romieu C
    J Radiol Electrol Med Nucl; 1968; 49(6):527-31. PubMed ID: 5724101
    [No Abstract]   [Full Text] [Related]  

  • 33. [Malignant goiter. Treatment and follow-up of 70 patients].
    Grewe HE; Marx E
    Med Welt; 1968 Dec; 51():2801-7. PubMed ID: 5716322
    [No Abstract]   [Full Text] [Related]  

  • 34. [Indications and results of endemic goiter drug therapy with synthetic thyroid hormones].
    Horster FA; Wildmeister W
    Acta Endocrinol Suppl (Copenh); 1973 Oct; 179():89-90. PubMed ID: 4523787
    [No Abstract]   [Full Text] [Related]  

  • 35. THE GROWTH AND FUNCTION OF THIOURACIL-INDUCED THYROID TUMORS TRANSPLANTED INTO NON-INBRED RATS THYMECTOMIZED AT BIRTH.
    MONEY WL; TYPOND P; RAWSON RW
    Cancer Res; 1965 May; 25():423-31. PubMed ID: 14297477
    [No Abstract]   [Full Text] [Related]  

  • 36. Changing end results in patients with papillary carcinoma of the thyroid.
    Crile G
    Surg Gynecol Obstet; 1971 Mar; 132(3):460-8. PubMed ID: 5546300
    [No Abstract]   [Full Text] [Related]  

  • 37. [Diagnosis and treatment of goiter suffering].
    Pietsch P; Dabels J; Schwartz KD
    Zentralbl Chir; 1972 Sep; 97(36):1265-76. PubMed ID: 4117052
    [No Abstract]   [Full Text] [Related]  

  • 38. The use of thyroid-stimulating hormone-Edecrine pretreatment in the radioiodide therapy of metastatic thyroid cancer. Clinical tolerance and changes in the radioiodine kinetics.
    Nĕmec J; Silink K; Neradilová M; Zamrazil V; Vána S; Cenková V
    Neoplasma; 1972; 19(2):125-33. PubMed ID: 4112457
    [No Abstract]   [Full Text] [Related]  

  • 39. [The possibilities of the use of exogenous TSH in the treatment of thyroid cancer metastases].
    Dargent M; Berger M; Lahneche B; Colon J; Bigot P; Henry P
    Mem Acad Chir (Paris); 1966 Feb 2-9; 92(4):142-51. PubMed ID: 5905829
    [No Abstract]   [Full Text] [Related]  

  • 40. [Control of the distribution of radioactivity in the organism following therapeutic administration of radioactive iodine (131-I) in patients with cancer of the thyroid gland].
    Nĕmec J; Vohnout S; Vána S; Valenta L; Röhling S
    Vnitr Lek; 1968 Dec; 14(12):1169-75. PubMed ID: 5726690
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.